Oaktree Specialty Lending Corporation (OCSL) reported Q4 fiscal 2026 results on November 17, 2026, showing credit quality gains offset by declining earnings. Adjusted net investment income fell to $0.34 per share from $0.37 in the prior quarter. Non-accrual loans dropped 44% year-over-year to 1.8% of the debt portfolio at fair value, down in dollar terms from $81 million to $45 million.
For full fiscal year 2026, adjusted net investment income declined to $1.49 per share from $1.76 in fiscal 2025, driven by lower average portfolio balances, softer reference rates, and higher incentive fees. OCSL declared a quarterly cash distribution of $0.32 per share, including a $0.02 supplemental dividend, payable December 31, 2026.
Net asset value per share slipped to $15.63 from $15.70 at June 30, 2026. The portfolio totaled $2.7 billion at fair value across 170 portfolio companies, with weighted average yield on debt investments of 9.4%. New investment commitments reached $179 million at a weighted average yield of 9.6%.
Portfolio composition shows 83% senior secured investments and 91% floating-rate debt. Software and Services represented 20% of the portfolio, Health Care Equipment and Services 17%, and Capital Goods 11%. First lien loans dominated at 79% of the $2.7 billion portfolio.
OCSL ended the quarter with net debt-to-equity of 1.00x, down from 1.02x, within its target range of 0.90x to 1.25x. Total debt outstanding was $1,416 million. In September 2026, the company issued $300 million of 5-year unsecured bonds at Treasury plus 240 basis points, swapped to SOFR plus 258 basis points. Moody's revised its outlook to stable during the quarter.
OCSL stock traded at $11.81, down 1.83% in premarket trading after the earnings release. Shares sit 11.8% above the 52-week low of $10.63 but 15.1% below the 52-week high of $13.905.